First Oral Drug for Moderate-To-Severe Ulcerative Colitis

被引：0
|
作者：
Aschenbrenner, Diane S.
机构：
来源：
AMERICAN JOURNAL OF NURSING | 2018年 / 118卷 / 09期
关键词：
D O I：
暂无
中图分类号：
R47 [护理学];
学科分类号：
1011 ;
摘要：
Immediate-release tofacitinib (Xeljanz) is now approved to treat moderate-to-severe ulcerative colitis. Nurses should assess patients for infections prior to the initiation of and throughout tofacitinib treatment.
引用
收藏
页码：22 / 22
页数：1
相关论文
共 50 条
  • [41] Induction with infliximab and a plant-based diet as first-line (IPF) therapy for moderate-to-severe to severe ulcerative colitis
    Chiba, Mitsuro
    Nakane, Kunio
    Tsuji, Tsuyotoshi
    Tsuda, Satoko
    Ishii, Hajime
    Ohno, Hideo
    Watanabe, Kenta
    Ito, Mai
    Obara, Yu
    Komatsu, Masafumi
    Sugawara, Takeshi
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2018, 33 : 483 - 483
  • [42] Peficitinib, an Oral Janus Kinase Inhibitor, in Moderate-to-severe Ulcerative Colitis: Results From a Randomised, Phase 2 Study
    Sands, Bruce E.
    Sandborn, William J.
    Feagan, Brian G.
    Lichtenstein, Gary R.
    Zhang, Hongyan
    Strauss, Richard
    Szapary, Philippe
    Johanns, Jewel
    Panes, Julian
    Vermeire, Severine
    O'Brien, Christopher D.
    Yang, Zijiang
    Bertelsen, Kirk
    Marano, Colleen
    JOURNAL OF CROHNS & COLITIS, 2018, 12 (10): : 1158 - 1169
  • [43] Oral Ritlecitinib and Brepocitinib for Moderate-to-Severe Ulcerative Colitis: Results From a Randomized, Phase 2b Study
    Sandborn, William J.
    Danese, Silvio
    Leszczyszyn, Jaroslaw
    Romatowski, Jacek
    Altintas, Engin
    Peeva, Elena
    Hassan-Zahraee, Mina
    Vincent, Michael S.
    Reddy, Padmalatha S.
    Banfield, Christopher
    Salganik, Mikhail
    Banerjee, Anindita
    Gale, Jeremy D.
    Hung, Kenneth E.
    CLINICAL GASTROENTEROLOGY AND HEPATOLOGY, 2023, 21 (10) : 2616 - 2628
  • [44] Peripheral Blood DNA Methylation Signatures and Response to Tofacitinib in Moderate-to-severe Ulcerative Colitis
    Joustra, Vincent
    Li Yim, Andrew Y. F.
    van Gennep, Sara
    Hageman, Ishtu
    de Waard, Tristan
    Levin, Evgeni
    Lauffer, Peter
    de Jonge, Wouter
    Henneman, Peter
    Loewenberg, Mark
    D'Haens, Geert
    JOURNAL OF CROHNS & COLITIS, 2023, 18 (08): : 1179 - 1189
  • [45] Systematic review and network meta-analysis of treatment for moderate-to-severe ulcerative colitis
    Trigo-Vicente, Cristina
    Gimeno-Ballester, Vicente
    Garcia-Lopez, Santiago
    Lopez-Del Val, Alejandro
    INTERNATIONAL JOURNAL OF CLINICAL PHARMACY, 2018, 40 (06) : 1411 - 1419
  • [46] Infliximab in the treatment of moderate-to-severe ulcerative colitis: Results of a large multicenter Italian survey
    Cappello, M.
    Mazza, M.
    Costantino, G.
    Fries, W.
    Privitera, A. C.
    Mastronardi, M.
    Bossa, F.
    Rispo, A.
    Castiglione, F.
    Lauria, A.
    Buccianti, N.
    Marasco, R.
    Grossi, L.
    Principi, M. B.
    JOURNAL OF CROHNS & COLITIS, 2014, 8 : S252 - S252
  • [47] Psychometric Properties of the Ulcerative Colitis Electronic Diary (UC e-Diary) in Adult Patients with Moderate-to-Severe Ulcerative Colitis
    Tahir, Muna J.
    Shahraz, Saeid
    Wang, Song
    Nagy, Peter
    Kamble, Pravin
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2021, 116 : S427 - S427
  • [48] Management of moderate to severe ulcerative colitis
    D'Haens, G.
    Emerging Issues in Inflammatory Bowel Diseases, 2006, 151 : 174 - 180
  • [49] Subcutaneous Golimumab Induces Clinical Response and Remission in Patients With Moderate-to-Severe Ulcerative Colitis
    Sandborn, William J.
    Feagan, Brian G.
    Marano, Colleen
    Zhang, Hongyan
    Strauss, Richard
    Johanns, Jewel
    Adedokun, Omoniyi J.
    Guzzo, Cynthia
    Colombel, Jean-Frederic
    Reinisch, Walter
    Gibson, Peter R.
    Collins, Judith
    Jarnerot, Gunnar
    Hibi, Toshifumi
    Rutgeerts, Paul
    GASTROENTEROLOGY, 2014, 146 (01) : 85 - 95
  • [50] Systematic review and network meta-analysis of treatment for moderate-to-severe ulcerative colitis
    Cristina Trigo-Vicente
    Vicente Gimeno-Ballester
    Santiago García-López
    Alejandro López-Del Val
    International Journal of Clinical Pharmacy, 2018, 40 : 1411 - 1419
12345